Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

Broadening perspectives:

Advancing the care of people
with diabetes

27 November 2021

Broadening perspectives:
Advancing the care of people with diabetes

This year, the All-Ireland conference brings you the latest thinking and practical advice on diabetes in the primary care setting, and will be doing so in a virtual format. Covering a broad range of topics, the speakers will highlight what new initiatives and changes mean for you in your everyday practice. The mix of lectures from leading healthcare professionals and interactive practical workshops will enable you – whatever your role in the primary care diabetes team – to come away having consolidated and built on your knowledge. You will also be able to work through the online CPD/CME templates throughout the day that you can take away to add to your personal development portfolio, all aimed at helping you put what you learn into practice.

We hope you will join us, virtually, for what is sure to be another invaluable event for your professional development.

Irish Representatives of the PCDS

Joanne Lowe, Community Diabetes Nurse Specialist, Co Wicklow

Lisa Devine, GP, Co. Wicklow

Why attend? This fast-paced, interactive conference combines latest clinical guidance, research, case studies and hot topics in diabetes, including lessons learned from COVID-19 and much more.

Ask the experts your burning questions through the LIVE Q&A at the end of each session

Log on anytime during the day from the comfort of your own home to view the sessions

Don’t worry if you miss something, all of the content will be available on-demand

Claim 5 CPD/CME points points for the full-day virtual conference

27 November 2021

Days
Hours
Minutes
Seconds

Agenda

09.00 - 09.10

Chair’s introduction

Joanne Lowe

09.10 - 09.40

Understanding and managing cardiorenal metabolic disease

  • Cardiovascular and renal disease, the relationship with diabetes
  • Additional factors, hypertension, dyslipidemia and insulin resistance
  • New medications and guidance

Paul Mcmullan

15 minute break

09.55–10.25

Symposium

15 minute break

10.40–11.10

Language matters: Overcoming common communication hurdles

  • Adapting your communication strategies for different ages and cultures
  • Addressing health beliefs and understanding health literacy

Mark Davies

15 minute break

11.25 - 12.05

‘In Practice’ masterclasses

Rotation 1

1. Severe mental illness and learning difficulties

  • The risk of diabetes in people with severe mental illness
  • Improving diabetes care for people with learning difficulties
  • Resources available to make diabetes education accessible to your patients

Peter Bagshaw

2. Diabetes and pre-pregnancy

  • Pre-conception care for women with diabetes: Key considerations
  • The Pregnancy Model of Care: An overview and assessing the impact on our practice

Ciara Coveney and Yvonne Moloney

3. 100 years of insulin: the last 100 years and looking forward and titration

  • 100 years of insulin: achievements
  • Insulin titration: overview of current best practice
  • Looking forward: hopes for future developments for insulin

4. Type 2 diabetes – Supporting more effective clinical management in routine care

  • Making sense of reports to improve clinical outcomes
  • Helping patients to help themselves
  • Enabling discussion to improve Time in range

 

Session organised and supported by Abbott Laboratories Ltd.

Fraser Gibb

15 minute break

12.20–13.00

‘In Practice’ masterclasses

Rotation 2

1. Severe mental illness and learning difficulties

  • The risk of diabetes in people with severe mental illness
  • Improving diabetes care for people with learning difficulties
  • Resources available to make diabetes education accessible to your patients

Peter Bagshaw

2. Diabetes and pre-pregnancy

  • Pre-conception care for women with diabetes: Key considerations
  • The Pregnancy Model of Care: An overview and assessing the impact on our practice

Ciara Coveney and Yvonne Moloney

3. 100 years of insulin: the last 100 years and looking forward and titration

  • 100 years of insulin: achievements
  • Insulin titration: overview of current best practice
  • Looking forward: hopes for future developments for insulin

15 minute break

13.15 - 13.45

Obesity and diabetes: Improving health and DiRECTing diabetes remission

  • Examining the issues around diabetes and obesity including COVID-19, GLP-1s and possible remission
  • Providing an update on the DiRECT trial
  • Does bariatric surgery have a role to play

Roy Harper

15 minute break

14.00-14.30

Symposium

15 minute break

14.45–15.15

Diabetes Distilled: Providing an update on diabetes in primary care

  • Latest evidence and developments
  • Diabetes in a post-COVID world
  • New medication and technology
  • Current guidelines and how they apply to primary care

Kevin Fernando

15.15–15.25

Chair’s concluding remarks

Joanne Lowe

Speakers

Peter-Bagshaw_SQ.jpg

Peter Bagshaw

General Practitioner, Associate Clinical Director for Mental Health, and Dementia and Learning disabilities at Somerset CCG

F_Place.png

Ciara Coveney

Registered Advanced Midwife Practitioner, National Maternity Hospital, Dublin

Mark-Davies_1.png

Mark Davies

Consultant Clinical Psychologist, Belfast Health and Social Care Trust

Lisa_Devine_v2

Lisa Devine

GP, Co. Wicklow

Kevin-Fernando

Kevin Fernando

GPwSI in Diabetes and Medical Education, North Berwick

Fraser-Gibb

Fraser Gibb

Consultant Endocrinologist and Honorary Senior Lecturer

Roy_Harper

Roy Harper

Consultant Physician and Visiting Professor, Belfast

Speaker Images_1

Joanne Lowe

Community Diabetes Nurse Specialist, Co. Wicklow

F_Place.png

Yvonne Moloney

Registered Advanced Midwife Practitioner RAMP Diabetes, UL Hospitals Group, University Maternity Hospital

Paul-McMullen.jpg

Paul McMullan

Consultant Endocrinology and Diabetes

Taking place on:

A full-day virtual conference

27 November 2021 from 9am

Including a LIVE Q&A after every session

Conference Sponsors

GOLD SPONSOR

Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission.

To learn more, visit www.lilly.ie

SILVER SPONSORS

Napp Pharmaceuticals Limited

Napp Pharmaceuticals Limited is a UK healthcare company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients. We strive to offer new medicines and initiatives that support the NHS in delivering effective, high-quality, sustainable healthcare for the benefit of patients

Masterclass sponsor

Abbott’s diabetes care division

At Abbott, we believe people with diabetes should have the freedom to enjoy a full, active life. That’s why we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor their glucose and providing healthcare teams with more data to drive better informed treatment decisions.

BRONZE SPONSORS

Boehringer Ingelheim and Lilly Diabetes Alliance

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care.  This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: diabetes, haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 43,200 people in 80 countries and markets its products in more than 170 countries. Every day, millions of people all over the world rely on our products, which are manufactured in nine countries.
Novo Nordisk has a unique ownership structure, with two-thirds of Novo Nordisk’s shares controlled by the Novo Nordisk Foundation. The objective of the Foundation is to provide a stable basis for the commercial and research activities of Novo Nordisk and support scientific, humanitarian and social purposes.
As the acknowledged leader in diabetes care, we work to prevent, treat and ultimately cure this increasingly onerous disease. Over the past 90 years, our researchers have pioneered many breakthroughs in its management, and today, our determination to help these people is stronger than ever.
Novo Nordisk also holds leading positions in the management of bleeding disorders, growth hormone treatment and hormone replacement therapy. We are currently researching into novel delivery systems and autoimmune and chronic inflammatory diseases, using technologies such as translational immunology and monoclonal antibodies.

This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

21 November 2020

Complete the registration form

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.

21 November 2020

Days
Hours
Minutes
Seconds

Thanks for registering